Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Sara Tolaney, MD, MPH, Dana Farber Cancer Institute, Boston, MA, discusses pembrolizumab (pembro) in combination with palliative radiotherapy (radio) for hormone receptor-positive (HR+) metastatic breast cancer, This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).